A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion
May 24, 2022
Tags:
RoosterBio’s media platform for culturing mesenchymal stem cells (MSCs) reduces the time and cost limitations while generating billions of MSCs. Our Scientific Editor in Chief examines how this platform enables cell therapy companies to profitably bring their novel treatments to patients at a reasonable price.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
